National Cancer Institute U.S. National Institutes of Healthwww.cancer.gov
GEMES Contact Us
Lung and prostate cancer are leading causes of cancer morbidity and mortality world-wide. To date, no prevention, screening or therapeutic regimen has been proven to be effective against lung cancer, while metastatic prostate cancer remains a deadly disease of men. Moreover, not all population groups have equally benefited from the advances in cancer research. Thus differences in lung and prostate incidence and mortality exist among the various population groups in the United States. New approaches are urgently needed to improve the prevention and treatment of lung and prostate cancer. Those must integrate differences in cancer susceptibility and disease progression that arise at both the individual and population level.



GEMES Principal Investigators:

Stefan Ambs, Ph.D., MPH
Curtis Harris, M.D.
Laboratory of Human Carcinogenesis, CCR,
National Cancer Institute, NIH

home
Background
Statistics
Coordinating Center
Collaborators
Advisory Board
FAQs
Questionnaires
Data Sharing
Publications
Other Links
Dictionary